ATE455752T1 - Herstellung von (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpent namin - Google Patents

Herstellung von (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpent namin

Info

Publication number
ATE455752T1
ATE455752T1 AT07787803T AT07787803T ATE455752T1 AT E455752 T1 ATE455752 T1 AT E455752T1 AT 07787803 T AT07787803 T AT 07787803T AT 07787803 T AT07787803 T AT 07787803T AT E455752 T1 ATE455752 T1 AT E455752T1
Authority
AT
Austria
Prior art keywords
preparation
methoxyphenyl
namin
trimethylpent
trimethylpentanamine
Prior art date
Application number
AT07787803T
Other languages
English (en)
Inventor
Walter Ferdinand Maria Filliers
Rudy Laurent Maria Broeckx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE455752T1 publication Critical patent/ATE455752T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/64Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C07C217/66Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
    • C07C217/72Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
AT07787803T 2006-07-24 2007-07-23 Herstellung von (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpent namin ATE455752T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06117708 2006-07-24
PCT/EP2007/057559 WO2008012283A1 (en) 2006-07-24 2007-07-23 Preparation of (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpentanamine

Publications (1)

Publication Number Publication Date
ATE455752T1 true ATE455752T1 (de) 2010-02-15

Family

ID=37772663

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07787803T ATE455752T1 (de) 2006-07-24 2007-07-23 Herstellung von (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpent namin

Country Status (22)

Country Link
US (2) US8138376B2 (de)
EP (1) EP2046726B1 (de)
JP (1) JP5208933B2 (de)
KR (1) KR101370398B1 (de)
CN (1) CN101495447B (de)
AT (1) ATE455752T1 (de)
AU (1) AU2007278224C1 (de)
BR (1) BRPI0714671B8 (de)
CA (1) CA2656696C (de)
CY (1) CY1110075T1 (de)
DE (1) DE602007004494D1 (de)
DK (1) DK2046726T3 (de)
EA (1) EA015003B1 (de)
ES (1) ES2339403T3 (de)
HK (1) HK1134280A1 (de)
HR (1) HRP20100197T1 (de)
IL (1) IL196627A (de)
MX (1) MX2009000911A (de)
PL (1) PL2046726T3 (de)
PT (1) PT2046726E (de)
SI (1) SI2046726T1 (de)
WO (1) WO2008012283A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI401237B (zh) * 2006-07-24 2013-07-11 3-〔(1r,2r)-3-(二甲基氨基)-1-乙基-2-甲基丙基〕酚之製備
CN102002065B (zh) * 2009-09-02 2014-09-10 上海特化医药科技有限公司 他喷他多的制备方法及其中间体
US8288592B2 (en) 2009-09-22 2012-10-16 Actavis Group Ptc Ehf Solid state forms of tapentadol salts
IT1397189B1 (it) 2009-12-01 2013-01-04 Archimica Srl Nuovo processo per la preparazione di tapentadol e suoi intermedi.
AU2010337825A1 (en) * 2009-12-29 2012-07-05 Mapi Pharma Limited Intermediate compounds and processes for the preparation of tapentadol and related compounds
WO2011092719A2 (en) * 2010-02-01 2011-08-04 Ind-Swift Laboratories Limited Process for the preparation of l-phenyl-3-dimethylaminopropane derivatives
EP2542521A2 (de) 2010-03-05 2013-01-09 Actavis Group Ptc Ehf Verbessertes auflösungsverfahren zur isolierung von gewünschten enantiomeren aus tapentadolzwischenprodukten und ihre verwendung zur herstellung von tapentadol
EP2556048A2 (de) 2010-04-05 2013-02-13 Actavis Group PTC EHF Neuartiges verfahren zur herstellung hochreinen tapentadols oder eines pharmazeutisch akzeptablen salzes daraus
IT1401109B1 (it) * 2010-07-02 2013-07-12 Archimica Srl Nuovo processo per la preparazione di tapentadol e suoi intermedi.
EP3636629A1 (de) * 2010-07-23 2020-04-15 Grünenthal GmbH Salze oder co-kristalle aus 3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol
EP2619174A4 (de) 2010-09-20 2014-05-14 Ind Swift Lab Ltd Verfahren zur herstellung eines l-phenyl-3-dimethylaminopropanderivats
CN102477016B (zh) * 2010-11-26 2014-12-17 中国医学科学院药物研究所 他喷他多的中间体的合成与应用
CZ302993B6 (cs) * 2010-12-30 2012-02-08 Zentiva, K.S. Zpusob výroby (2R,3R)-N,N-dimethyl-3-(3-hydroxyfenyl)-2-methylpentylaminu (tapentadolu)
CZ2010997A3 (cs) * 2010-12-30 2012-02-08 Zentiva, K.S. Zpusob výroby (2R,3R)-N,N-dimethyl-3-(3-hydroxyfenyl)-2-methylpentylaminu (tapentadolu)
CZ303115B6 (cs) * 2010-12-30 2012-04-11 Zentiva, K.S. Zpusob výroby (2R,3R)-N,N-dimethyl-3-(3-hydroxyfenyl)-2-methylpentylaminu
WO2012089181A1 (en) * 2010-12-30 2012-07-05 Zentiva, K.S. O-substituted (2r,3r)-3-(3-hydroxyphenyl)-2-methyl-4-pentenoic acids and a method of obtaining the same
CN102617501A (zh) * 2011-01-31 2012-08-01 中国科学院上海药物研究所 取代正戊酰胺类化合物、其制备方法及用途
RS56692B1 (sr) 2011-03-04 2018-03-30 Gruenenthal Gmbh Polučvrsta vodena farmaceutska kompozicija koja sadrži tapentadol
EA024193B1 (ru) * 2011-03-04 2016-08-31 Грюненталь Гмбх Фармацевтическая композиция на водной основе, предназначенная для парентерального введения тапентадола
DK2680832T3 (da) 2011-03-04 2019-10-14 Gruenenthal Gmbh Vandig farmaceutisk formulering af tapentadol til oral administration
CN102206164A (zh) * 2011-04-11 2011-10-05 中国药科大学 一种他喷他多中间体的制备方法
WO2012146978A2 (en) 2011-04-28 2012-11-01 Actavis Group Ptc Ehf A novel process for the preparation of tapentadol or a pharmaceutically acceptable salt thereof
WO2013090161A1 (en) 2011-12-12 2013-06-20 Boehringer Ingelheim International Gmbh Stereoselective synthesis of tapentadol and its salts
WO2013120466A1 (en) 2012-02-17 2013-08-22 Zentiva, K.S. A new solid form of tapentadol and a method of its preparation
EP2674414A1 (de) 2012-06-15 2013-12-18 Siegfried AG Verfahren zur Herstellung von 1-aryl-1-alkyl-3-dialkylaminopropan-Verbindungen
CN103159633B (zh) * 2012-07-06 2015-08-12 江苏恩华药业股份有限公司 他喷他多的制备方法及用于制备他喷他多的化合物
WO2015075678A1 (en) 2013-11-21 2015-05-28 Unimark Remedies Ltd. A novel process for the preparation of 1-phenyl-3-aminopropane derivatives
EP3083551B1 (de) 2013-12-16 2018-02-14 Farma GRS, d.o.o. Kristalline form eines tapendatol-zwischenprodukts
CN104725287A (zh) * 2013-12-20 2015-06-24 北京蓝贝望生物医药科技股份有限公司 一种对甲苯磺酸酯的制备方法与应用
CZ307492B6 (cs) 2014-02-04 2018-10-17 Zentiva, K.S. Pevná forma maleátu tapentadolu a způsob její přípravy
BR112017018569A2 (pt) 2015-03-27 2018-04-24 Gruenenthal Gmbh formulação estável para administração parentérica de tapentadol
CN106278915A (zh) * 2015-05-19 2017-01-04 重庆圣华曦药业股份有限公司 一种制备他喷他多中间体的方法
EP3319941B1 (de) 2015-07-10 2021-12-29 SpecGx LLC Zweistufiges verfahren zur herstellung von 3-substituierten phenylalkylaminen
EA201990744A1 (ru) 2016-09-23 2019-08-30 Грюненталь Гмбх Стабильная лекарственная форма для парентерального введения тапентадола
SK812017A3 (sk) * 2017-08-18 2019-03-01 Saneca Pharmaceuticals A. S. Spôsob prípravy tapentadolu a jeho medziproduktov
US20210253513A1 (en) 2018-06-15 2021-08-19 Pharmathen S.A. A novel process for the preparation of tapentadol
AU2020245333A1 (en) * 2019-03-28 2021-10-28 Council Of Scientific And Industrial Research Process for the preparation of tapentadol and analogs thereof
EP4116288A1 (de) 2021-07-08 2023-01-11 KRKA, d.d., Novo mesto Racemisierung von (s) und/oder (r)-3-(dimethylamino)-1-(3-methoxyphenyl)-2-methylpropan-1-on und mischungen davon
EP4269384A1 (de) 2022-04-26 2023-11-01 KRKA, d.d., Novo mesto Verfahren zur kristallisation eines tapentadolzwischenprodukts, tapentadolzwischenprodukt hoher reinheit, verfahren zur herstellung von tapentadol und tapentadol hoher reinheit

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60188333A (ja) * 1984-03-07 1985-09-25 Ihara Chem Ind Co Ltd ハロゲン化ベンゼン類の製造方法
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
DE19609847A1 (de) * 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
EP1188433B1 (de) * 2000-09-14 2007-01-03 Firmenich Sa Verwendung von ungesättigten Estern als Duftstoffe
DE10326097A1 (de) * 2003-06-06 2005-01-05 Grünenthal GmbH Verfahren zur Herstellung von Dimethyl-(3-aryl-butyl)-aminverbindungen
DE10328316A1 (de) 2003-06-23 2005-01-20 Grünenthal GmbH Verfahren zur Herstellung von Dimethyl-(3-aryl-buthyl)-aminverbindungen als pharmazeutische Wirkstoffe
TWI401237B (zh) * 2006-07-24 2013-07-11 3-〔(1r,2r)-3-(二甲基氨基)-1-乙基-2-甲基丙基〕酚之製備

Also Published As

Publication number Publication date
PL2046726T3 (pl) 2010-06-30
KR101370398B1 (ko) 2014-03-05
AU2007278224B2 (en) 2011-09-15
EP2046726B1 (de) 2010-01-20
JP5208933B2 (ja) 2013-06-12
IL196627A0 (en) 2009-11-18
DK2046726T3 (da) 2010-05-10
EP2046726A1 (de) 2009-04-15
CA2656696A1 (en) 2008-01-31
KR20090033444A (ko) 2009-04-03
PT2046726E (pt) 2010-04-15
CN101495447B (zh) 2013-05-29
BRPI0714671B8 (pt) 2023-03-21
HK1134280A1 (de) 2010-04-23
WO2008012283A1 (en) 2008-01-31
DE602007004494D1 (de) 2010-03-11
AU2007278224A1 (en) 2008-01-31
SI2046726T1 (sl) 2010-05-31
JP2009544658A (ja) 2009-12-17
BRPI0714671B1 (pt) 2020-09-24
US8138376B2 (en) 2012-03-20
US20120142970A1 (en) 2012-06-07
AU2007278224C1 (en) 2012-06-21
HRP20100197T1 (hr) 2010-05-31
US8440863B2 (en) 2013-05-14
EA200970147A1 (ru) 2009-08-28
CY1110075T1 (el) 2015-01-14
IL196627A (en) 2013-06-27
MX2009000911A (es) 2009-02-04
CN101495447A (zh) 2009-07-29
EA015003B1 (ru) 2011-04-29
CA2656696C (en) 2013-06-11
ES2339403T3 (es) 2010-05-19
BRPI0714671A2 (pt) 2013-05-07
US20090312578A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
ATE455752T1 (de) Herstellung von (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpent namin
CY1124873T1 (el) Διεργασια για την παρασκευη (1r,2r)-3-(3-διμεθυλαμινο-1-αιθυλο-2-μεθυλο-προπυλο)-φαινολης
ATE515491T1 (de) Herstellung von 3-ä(1r,2r)-3-(dimethylamino)- 1ethyl-2-methylpropylüphenol
EA201100094A1 (ru) Тиадиазолилоксифениламидины и их применение в качестве фунгицидов
EA200900098A1 (ru) Пептидные соединения для лечения расстройств, связанных с повышенной возбудимостью, и болезней, связанных с дисфункцией ионных каналов
EA201100093A1 (ru) Тиадиазолилоксифениламидины и применение их в качестве фунгицидов
MX2007005936A (es) Una sintesis asimetrica del acido (s)-(+)-3-(aminometil)-5- metilhexanoico.
BRPI0507308A (pt) nanossuspensões de agentes anti-retrovirais para entrega ao sistema nervoso central aumentada
EA201100727A1 (ru) Новый способ получения производных аминокислот
EA201190144A1 (ru) Изотиазолилоксифениламидины и их применение в качестве фунгицидов
EA200801560A1 (ru) Бифенилкарбоксамиды
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
EA201070853A1 (ru) Кристаллический (r)-2-(4-циклопропансульфонилфенил)-n-пиразин-2-ил-3-(тетрагидропиран-4-ил)пропионамид
EA201000814A1 (ru) 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
EA200970126A1 (ru) Способ получения прегабалина и его энантиомера
ITMI20050249A1 (it) Procedimento per la preparazione di tolterodina
MX2010009931A (es) Proceso para la preparacion de 2-amino-2-[2-(4-c3-c21-alquil-fenil )-etil]-propano-1,3-dioles.
CO6390054A2 (es) Formas cristalinas de un compuesto 3-carboxipropil-aminotetralina
EA201071164A1 (ru) Жидкие и лиофилизованные композиции
ATE546451T1 (de) Cyclopropancarbonsäureester von acyclovir
EA201170072A1 (ru) Способ асимметричного синтеза замещенных 2-аминотиазолонов
CL2011000932A1 (es) Proceso para la preparacion de 9-diclorometilen-1,2,3,3-tetrahidro-1,4-metano-naftalen-5-ilamina; compuesto intermedio y proceso para preparar 6,6-diclorfulveno.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2046726

Country of ref document: EP